Author:
Liu Yuewen,Liu Yanfang,Cai Chaohong,Hui Fuhai,Zhang Yan,Wang Boqian,Wang Xueyi,Zhang Yijian,Song Xing,He Long,Yang Hongwei
Reference15 articles.
1. COVID-19 in solid organ transplant recipients: initial report from the US epicenter;Pereira;Am J Transplant,2020
2. Mortality in solid organ transplant recipients with COVID-19: more than meets the eye;Maggiore;Am J Transplant,2022
3. The path to Paxlovid: how Pfizer scientists transformed an old drug lead into an oral COVID-19 antiviral;Larry;Chem Eng News,2022
4. Kumar D, Humar A, Ison MG, Kaul D, Blumberg E, Theodoropoulos N, et al. AST statement on oral antiviral therapy for COVID-19 for organ transplant recipients by the American Society of Transplantation, https://www.healthytransplant.com/sites/default/files/AST%20Statement%20on%20Oral%20Antiviral%20Therapy%20for%20COVID%20Jan%204%20%282%29.pdf; 2022 [accessed 03.22.22].
5. Therapeutic drug monitoring of tacrolimus-personalized therapy: second consensus report;Brunet;Therap Drug Monitor,2019
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献